We are live on ! Find out more
RA

Rise Advisors Portfolio holdings

AUM $355M
1-Year Est. Return 20.51%
This Fund
S&P 500
This Quarter Est. Return
+1.22%
1 Year Est. Return
+20.51%
3 Year Est. Return
+58.86%
5 Year Est. Return
10 Year Est. Return
AUM
$189M
AUM Growth
+$1.05M
Cap. Flow
+$36K
Cap. Flow %
0.02%
Top 10 Hldgs %
60.04%
Holding
1,290
New
25
Increased
567
Reduced
127
Closed
51

Sector Composition

Rank Sector Weight
1 Technology 7.86%
2 Financials 6.64%
3 Consumer Discretionary 3.8%
4 Industrials 3.53%
5 Healthcare 3.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XYZ
1076
Block Inc
XYZ
$45.9B
$5.09K ﹤0.01%
79
-30
-28% -$2.1K
ARTY
1077
iShares Future AI & Tech ETF
ARTY
$3.49B
$5.01K ﹤0.01%
151
+1
+0.7% +$33
EBTC
1078
DELISTED
Enterprise Bancorp
EBTC
$5K ﹤0.01%
+201
New +$4.92K
UPST icon
1079
Upstart Holdings
UPST
$2.58B
$4.95K ﹤0.01%
210
BSMT icon
1080
Invesco BulletShares 2029 Municipal Bond ETF
BSMT
$278M
$4.88K ﹤0.01%
213
-3
-1% -$69
LARK icon
1081
Landmark Bancorp
LARK
$192M
$4.82K ﹤0.01%
277
+2
+0.7% +$35
Z icon
1082
Zillow
Z
$7.04B
$4.78K ﹤0.01%
103
-40
-28% -$1.76K
PLUG icon
1083
Plug Power
PLUG
$2.92B
$4.66K ﹤0.01%
+2,000
New +$5.73K
WABC icon
1084
Westamerica Bancorp
WABC
$1.39B
$4.63K ﹤0.01%
95
+50
+111% +$2.39K
MCHI icon
1085
iShares MSCI China ETF
MCHI
$6.04B
$4.57K ﹤0.01%
108
JD icon
1086
JD.com
JD
$40.8B
$4.45K ﹤0.01%
172
+34
+25% +$998
KBE icon
1087
State Street SPDR S&P Bank ETF
KBE
$1.64B
$4.19K ﹤0.01%
90
KODK icon
1088
Kodak
KODK
$806M
$4.17K ﹤0.01%
776
MACK
1089
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$4.11K ﹤0.01%
272
TWLO icon
1090
Twilio
TWLO
$29.1B
$4.09K ﹤0.01%
72
PUBM icon
1091
PubMatic
PUBM
$581M
$4.06K ﹤0.01%
200
-50
-20% -$1.11K
CBOE icon
1092
Cboe Global Markets
CBOE
$29.8B
$3.88K ﹤0.01%
23
-15
-39% -$2.66K
ESGE icon
1093
iShares ESG Aware MSCI EM ETF
ESGE
$6.51B
$3.67K ﹤0.01%
109
AVAV icon
1094
AeroVironment
AVAV
$7.57B
$3.64K ﹤0.01%
20
BRC icon
1095
Brady Corp
BRC
$4.45B
$3.3K ﹤0.01%
+50
New +$3.13K
CRSP icon
1096
CRISPR Therapeutics
CRSP
$4.58B
$3.24K ﹤0.01%
60
AMRX icon
1097
Amneal Pharmaceuticals
AMRX
$5.72B
$3.17K ﹤0.01%
500
FLGT icon
1098
Fulgent Genetics
FLGT
$559M
$3.12K ﹤0.01%
159
-27
-15% -$564
GRC icon
1099
Gorman-Rupp
GRC
$2.16B
$3.08K ﹤0.01%
+84
New +$2.97K
CLDX icon
1100
Celldex Therapeutics
CLDX
$2.77B
$3.07K ﹤0.01%
83

Similar funds

Rise Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Rise Advisors held 1,290 positions worth $189M, up 0.56% from $188M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Rise Advisors's Q2 2024 filing shows 25 new, 567 increased, 127 reduced and 51 closed positions. Its largest new stake was Core Scientific: 7,000 shares worth $65.1K. The largest sale was State Street Financial Select Sector SPDR ETF, an estimated $3.15M.

By sector, the portfolio is most concentrated in Technology at 7.9% of assets, up from 7.1% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Rise Advisors's largest Q2 2024 buy was Core Scientific: 7,000 shares worth $65.1K.
  • Rise Advisors added most to Dimensional Core Fixed Income ETF in Q2 2024, an estimated $1.6M increase.
  • Rise Advisors's biggest Q2 2024 reduction was State Street Financial Select Sector SPDR ETF, cutting an estimated $3.15M.
  • Rise Advisors fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $85.1K.
  • Rise Advisors's ten largest holdings make up 60% of its $189M portfolio in Q2 2024.
  • Rise Advisors opened 25 new positions and closed 51 in Q2 2024.
  • Rise Advisors's portfolio value rose 0.56% quarter-over-quarter to $189M.

Based on Rise Advisors's 13F filing for Q2 2024, filed 9 Jul 2024.